Elevated mazes as animal models of anxiety: effects of serotonergic agents (original ) (raw )Antipanic-like effect of serotonin reuptake inhibitors in the elevated T-maze
Milena de Barros Viana
Behavioural Brain Research, 2003
View PDFchevron_right
Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: A novel test of anxiety in the rat
Sandra File
Pharmacology Biochemistry and Behavior, 1986
View PDFchevron_right
Comparison of acute and chronic treatment of various serotonergic agents with those of diazepam and idazoxan in the rat elevated X-maze
N. Upton
Psychopharmacology, 1992
View PDFchevron_right
Validation of open : closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
Sandra File
Journal of Neuroscience Methods, 1985
View PDFchevron_right
Behavioral Effects of Acute and Chronic Imipramine in the Elevated T-Maze Model of Anxiety
Hélio Zangrossi
Pharmacology Biochemistry and Behavior, 2000
View PDFchevron_right
The use of the elevated plus maze as an assay of anxiety-related behavior in rodents
Cheryl Frye
Nature protocols, 2007
View PDFchevron_right
Handling history of rats modifies behavioural effects of drugs in the elevated plus-maze test of anxiety
Sandra File
European Journal of Pharmacology, 1993
View PDFchevron_right
Contrasting effects of acute and chronic treatment with imipramine and fluoxetine on inhibitory avoidance and escape responses in mice exposed to the elevated T-maze
rotimi owolabi
Brain Research Bulletin, 2009
View PDFchevron_right
Anxiolytic effects of serotonergic interventions in the shock-probe burying test and the elevated plus-maze test
Angela Robinson
Behavioural Brain Research, 1993
View PDFchevron_right
Comparative behavioural profile of newer antianxiety drugs on different mazes
Shrinivas Kulkarni
Indian journal of experimental biology, 2008
View PDFchevron_right
Use of the elevated plus maze in the search for novel anxiolytic agents
Mark Tricklebank
Trends in Pharmacological Sciences, 1995
View PDFchevron_right
Modulation of anxiety in rats evaluated in the elevated T-maze: Evidence of the relationship between substance P and diazepam
Thereza Christina Monteiro Lima
View PDFchevron_right
Facilitation of 5-HT2A/2C-mediated neurotransmission in the ventromedial hypothalamic nucleus decreases anxiety in the elevated T-maze
Hélio Zangrossi
Behavioural Brain Research, 2011
View PDFchevron_right
The elevated T-maze: A new animal model of anxiety and memory
Carlos Tomaz
Pharmacology Biochemistry and Behavior, 1994
View PDFchevron_right
Differences in anxiety-like behaviour within a batch of Wistar rats are associated with differences in serotonergic transmission, enhanced by acute SSRI administration and abolished by serotonin depletion
Jakob Näslund , Staffan Nilsson
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP), 2015
View PDFchevron_right
Comparison of the elevated plus and elevated zero mazes in treated and untreated male Sprague–Dawley rats: Effects of anxiolytic and anxiogenic agents
Charles Vorhees
Pharmacology Biochemistry and Behavior, 2011
View PDFchevron_right
Behavioral differences in an elevated plus-maze: correlation between anxiety and decreased number of GABA and benzodiazepine receptors in mouse cerebral cortex
Lembit Rägo
Naunyn-Schmiedeberg's Archives of Pharmacology, 1988
View PDFchevron_right
The Gerbil Elevated Plus-Maze I Behavioral Characterization and Pharmacological Validation
Vicki Coffin
Neuropsychopharmacology, 2002
View PDFchevron_right
Acute and chronic anxiogenic-like response to fluoxetine in rats in the elevated plus-maze: Modulation by stressful handling
Alain Renault
Behavioural Brain Research, 2011
View PDFchevron_right
Anxiolytic effect of intra-amygdala injection of midazolam and 8-hydroxy-2-(di-n-propylamino)tetralin in the elevated T-maze
Hélio Zangrossi
European Journal of Pharmacology, 1999
View PDFchevron_right
Ethopharmacological analysis of the effects of putative ‘anxiogenic’ agents in the mouse elevated plus-maze
Kareem Aboualfa
Pharmacology Biochemistry and Behavior, 1995
View PDFchevron_right
Anxiolytic-like effects observed in rats exposed to the elevated zero-maze following treatment with 5-HT2/5-HT3/5-HT4 ligands
Aaron Duke , laurent begue , Rob Bell
Scientific Reports, 2014
View PDFchevron_right
Panic-modulating effects of alprazolam, moclobemide and sumatriptan in the rat elevated T-maze
Rafael Gomes
Behavioural Brain Research, 2016
View PDFchevron_right
Utility of ethological analysis to overcome locomotor confounds in elevated maze models of anxiety
Colin T Dourish
View PDFchevron_right
Repeated DOI and SR 46349B treatments do not affect elevated plus-maze anxiety despite opposite effects on cortical 5-HT2A receptors
Pierre Mormède
1997
View PDFchevron_right
Serotonergic neurons in the median raphe nucleus regulate inhibitory avoidance but not escape behavior in the rat elevated T-maze test of anxiety
Hélio Zangrossi
Psychopharmacology, 2005
View PDFchevron_right
Differential neurochemical properties of central serotonergic transmission in Roman high- and low-avoidance rats
Daniele Lecca
Journal of Neurochemistry, 2004
View PDFchevron_right
A discrimmative stimulus produced by l-(3-Chlorophenyl)-piperazine (mCPP) as a putative animal model of anxiety
Harbans Lal
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1998
View PDFchevron_right
Effects of acute fluoxetine, paroxetine and desipramine on rats tested on the elevated plus-maze
Dominique Drapier
Behavioural brain research, 2007
View PDFchevron_right
Ethopharmacological analysis of rat behavior on the elevated plus-maze
Fernando Frei
Pharmacology Biochemistry and Behavior, 1994
View PDFchevron_right
The interplay of learning and anxiety in the elevated plus-maze
Sandra File
Behavioural Brain Research, 1993
View PDFchevron_right
On behalf of: British Association for Psychopharmacology
Camila Roncon
View PDFchevron_right